These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1250637)

  • 1. [Long-term-follow-up-study after measles-vaccination (author's transl)].
    Huber EG; Rannon L; Galffy G
    Padiatr Padol; 1976; 11(1):72-6. PubMed ID: 1250637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Measles vaccination with split vaccines and living vaccines (author's transl)].
    Stehr K; Enders-Ruckle G; Spiess H
    MMW Munch Med Wochenschr; 1975 Jul; 117(27):1159-64. PubMed ID: 808710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revaccination against measles--a pilot study.
    Watson GI; Nichols JA; Robshaw JR
    J R Coll Gen Pract; 1975 Dec; 25(161):863-73. PubMed ID: 1223275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epidemiological investigations on measles in unvaccinated and vaccinated children (author's transl)].
    Wiedermann G; Ambrosch F
    Wien Klin Wochenschr; 1976 Sep; 88(17):545-54. PubMed ID: 997537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroconversion after measles vaccination at nine and fifteen months of age.
    Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
    Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody response after measles immunization.
    Ariyasriwatana C; Kalayanarooj S; Pattamadilok S
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S701-6. PubMed ID: 14700170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled epidemiological study of live measles vaccines in Poland.
    Polish Measles Vaccination Committee
    Bull World Health Organ; 1971; 45(3):331-5. PubMed ID: 5316912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A long-term follow-up study on the efficacy of further attenuated live measles vaccine, Biken CAM vaccine.
    Isomura S; Morishima T; Nishikawa K; Hanada N; Rahman M; Terashima M; Kido S; Ueda S; Takahashi M
    Biken J; 1986 Mar; 29(1):19-26. PubMed ID: 3778422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination.
    Dilraj A; Sukhoo R; Cutts FT; Bennett JV
    Vaccine; 2007 May; 25(21):4170-4. PubMed ID: 17408818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Duration of immunity and occurrence of secondary vaccine failure following vaccination against measles, mumps and rubella].
    Trier H; Rønne T
    Ugeskr Laeger; 1992 Jul; 154(29):2008-13. PubMed ID: 1509566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles immunity after revaccination: results in children vaccinated before 10 months of age.
    Linnemann CC; Dine MS; Roselle GA; Askey PA
    Pediatrics; 1982 Mar; 69(3):332-5. PubMed ID: 7063289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of AIK-C measles vaccine in infants at 6 months with Schwarz vaccine at 9 months: a randomized controlled trial in Ghana.
    Nkrumah FK; Osei-Kwasi M; Dunyo SK; Koram KA; Afari EA
    Bull World Health Organ; 1998; 76(4):353-9. PubMed ID: 9803586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of urban measles mass campaigns for children aged 9-59 months in Mali.
    Kertesz DA; Touré K; Berthé A; Konaté Y; Bougoudogo F
    J Infect Dis; 2003 May; 187 Suppl 1():S69-73. PubMed ID: 12721894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune status following measles vaccination in infants and evaluation for the need of revaccination.
    Dutta AK; Singhal PK; Khare S; Kumari S; Mathur R; Mullick DN
    Indian Pediatr; 1989 Aug; 26(8):765-72. PubMed ID: 2620977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of live attenuated measles and mumps vaccines in children with acute leukemia.
    Torigoe S; Hirai S; Oitani K; Ito M; Ihara T; Iwasa T; Kamiya H; Sakurai M; Ueda S; Yamanishi K
    Biken J; 1981 Dec; 24(4):147-51. PubMed ID: 7346040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EPI vaccines-induced antibody prevalence in 8-9 year-olds in The Gambia.
    Viviani S; Mendy M; Jack AD; Hall AJ; Montesano R; Whittle HC
    Trop Med Int Health; 2004 Oct; 9(10):1044-9. PubMed ID: 15482396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of measles antibodies after 2 doses of measles vaccine in a postelimination environment.
    LeBaron CW; Beeler J; Sullivan BJ; Forghani B; Bi D; Beck C; Audet S; Gargiullo P
    Arch Pediatr Adolesc Med; 2007 Mar; 161(3):294-301. PubMed ID: 17339511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measles HI-antibody levels in Lagos children, Nigeria: a follow-up study to resurgence of measles in Lagos metropolis.
    Oyefolu AO; Omilabu SA
    West Afr J Med; 2001; 20(3):238-42. PubMed ID: 11922159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measles, mumps and rubella: control by vaccination.
    van Druten JA; de Boo T; Plantinga AD
    Dev Biol Stand; 1986; 65():53-63. PubMed ID: 3556777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of herd immunity in control of measles.
    Black FL
    Yale J Biol Med; 1982; 55(3-4):351-60. PubMed ID: 7180027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.